Legend Biotech Corp (LEGN : NASDAQ)
Common Stock
$17.00
USD
-0.67 (-3.79%)
Last updated: 2026-09-16
Get LEGN alerts:
LEGN
Legend Biotech Corp
WealthAwesomePerformance
1 Day
-3.79%
1 Week
-14.62%
1 Month
-17.68%
YTD
-49.28%
Key Statistics
Market Cap
$3.31B
52W High
$37.50
52W Low
$16.24
P/E Ratio
-
50 Day MA
$21.49
200 Day MA
$22.87
Beta
0.40
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 9/16/2026 | $17.86 | $18.04 | $16.86 | $17.00 | $17.00 | 3,527,110 |
| 9/15/2026 | $18.60 | $18.63 | $17.52 | $17.67 | $17.67 | 3,470,800 |
| 9/14/2026 | $18.80 | $18.80 | $18.21 | $18.53 | $18.53 | 3,248,100 |
| 9/11/2026 | $19.48 | $19.85 | $18.61 | $18.64 | $18.64 | 4,278,400 |
| 9/10/2026 | $19.70 | $19.88 | $19.15 | $19.19 | $19.19 | 1,823,700 |
| 9/9/2026 | $20.22 | $20.52 | $19.76 | $19.91 | $19.91 | 1,362,100 |
| 9/8/2026 | $21.63 | $21.97 | $20.43 | $20.49 | $20.49 | 1,589,400 |
| 9/4/2026 | $21.52 | $21.90 | $21.41 | $21.52 | $21.52 | 812,000 |
| 9/3/2026 | $21.96 | $22.05 | $21.52 | $21.75 | $21.75 | 1,317,300 |
| 9/2/2026 | $21.11 | $21.96 | $21.10 | $21.89 | $21.89 | 1,478,600 |
Analyst Price Targets
Based on 22 analysts covering LEGN · as of Sep 17, 2026
Wall Street analysts forecast LEGN stock price to rise 185.2% over the next 12 months.
Consensus
Buy4.45 / 5.00
Avg. Target
US$48.48
+185.2% Upside
Current Price
US$17.00
Last close
Analyst Breakdown (22 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on LEGN's historical volatility
30-Day Vol
57.0%
Annualized
90-Day Vol
69.3%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
US$14.22
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | US$16.02 | US$13.16 – US$19.50 |
| 60 trading days | US$15.09 | US$11.43 – US$19.94 |
| 90 trading days | US$14.22 | US$10.11 – US$20.00 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Legend Biotech Corp
Legend Biotech Corporation, through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe. Its lead product candidate is ciltacabtagene autoleucel, or cilta-cel, which is a chimeric antigen receptor (CAR-T) therapy for the treatment of multiple myeloma (MM). The company also has a portfolio of earlier-stage autologous CAR-T product candidates targeting various cancers, including acute lymphoblastic leukemia, gastric cancer, esophageal cancer, pancreatic cancer, colorectal cancer, small cell lung cancer, and non-small cell lung cancer. In addition, it develops allogeneic gamma delta CAR-T and allogeneic CAR-NK product candidates targeting B-cell maturation antigen (BCMA) for MM, which are in investigator-initiated Phase 1 clinical trials in China. The company has a collaboration and license agreement with Janssen Biotech, Inc. for the development and commercialization of cilta-cel, as well as a license agreement with Novartis Pharma AG for the development, manufacture, and commercialization of CAR-T cell therapies targeting delta-like ligand protein 3. Legend Biotech Corporation was founded in 2014 and is headquartered in Somerset, New Jersey.
Financials
- Revenue (TTM)
- $1.27B
- EBITDA
- $-41.60M
- Profit Margin
- -7.20%
- ROE (TTM)
- -8.08%
- EPS (Diluted)
- -0.48
- Book Value
- 6.35
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About LEGN.US
Market movers
Recent NASDAQ movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| DLXY | Delixy Holdings Limited Ordinary Shares | $2.29 | +451.81% |
| MEDS | DataMEDS AI, Inc. | $6.07 | +274.69% |
| SNYR | Synergy CHC Corp. Common Stock | $0.27 | +234.15% |
| QCLS | Q/C Technologies, Inc. | $0.96 | +118.45% |
| AEHL | Antelope Enterprise Holdings Ltd | $9.22 | +78.68% |
| ZTG | Zenta Group Company Limited | $1.18 | +75.33% |
| PDSB | PDS Biotechnology Corp | $0.99 | +69.25% |
| TPST | Tempest Therapeutics Inc | $1.21 | +60.18% |